Therefore, it is very important to explore whether the CX3CL1/CX3CR1 gene polymorphism is significantly related to the clinical treatment of ovarian cancer and to screen alleles related to clinical efficacy for the individualized treatment of ovarian cancer. The gene discussed is CX3CR1; the disease is ovarian carcinoma.